5 Best Low Volatility Blue Chip Stocks to Buy Now

2. Colgate-Palmolive Company (NYSE:CL)

Beta Value (5Y Monthly): 0.33

On April 7, UBS lowered its price recommendation on Colgate-Palmolive Company (NYSE:CL) to $98 from $100. It kept a Buy rating and said Q1 results across much of the consumer staples group should be “okay.” The analyst expects organic revenue growth to show some stabilization. The bigger focus is on forward guidance, as inflation is likely to put more pressure on earnings in the second half and possibly beyond.

A week earlier, on March 31, TD Cowen downgraded Colgate-Palmolive to Hold from Buy. The firm also cut its price target to $85 from $96 and reduced earnings estimates to reflect rising input costs. The analyst pointed to higher prices for oil-based inputs and tallow, which are up 40% compared to last year on the Chicago Mercantile Exchange. While some investors see Colgate’s presence in emerging markets as a source of pricing power, the firm noted that a 13% negative revision to consensus earnings expectations in 2022 suggests its “resilience may not be as strong as investors believe.” TD Cowen also said the company’s U.S. business may need additional investment to support sales, following weak results in 2025 and a slow start to 2026.

Colgate-Palmolive Company (NYSE:CL) operates across Oral Care, Personal Care, Home Care, and Pet Nutrition. Its Oral, Personal, and Home Care business spans North America, Latin America, Europe, Asia Pacific, and Africa/Eurasia, serving retailers, distributors, dentists, and skin health professionals.